New pill could help regrow hair in patchy hair loss
NCT ID NCT06104839
First seen Apr 22, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study tests an experimental drug called NXC736 for people with moderate to severe alopecia areata, a condition that causes patchy hair loss. About 73 adults aged 19 to 65 with stable hair loss for at least 6 months but less than 8 years will take the drug or a placebo for 12 weeks. The main goal is to see if the drug can safely help regrow hair.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Kyung Hee University Hospital at Gangdong
RECRUITINGSeoul, 05278, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seoul National University Hospital.
RECRUITINGSeoul, 03080, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.